Echo-guided aortic valve replacement (Echo TAVR)
Part of Heart & circulation clinical trials.
This trial tests a way to replace your aortic valve using only ultrasound (echo) instead of X-rays or dye. It may be a good fit if you have severe aortic stenosis and need to avoid contrast or radiation because of kidney problems or cancer risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic stenosis that causes symptoms and need a new valve.
- You cannot or choose not to have contrast dye or radiation (due to kidney disease or cancer risk).
- You have not had a previous aortic valve replacement.
- You do not have untreated major heart artery blockages needing treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new way to replace your aortic valve using a small tube through your armpit, guided only by ultrasound (echocardiography) instead of X-rays. It may be an option if you have severe aortic stenosis and are a good fit for this less invasive approach.
This study compares two ways of guiding a procedure to replace your aortic heart valve: using ultrasound (echo) instead of the usual X-ray (fluoroscopy). The aim is to see if the ultrasound method works just as well and is safer.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This study uses a catheter-based procedure to replace a severely leaking aortic valve without open-heart surgery. It may help people who have symptoms or heart damage from a leaky valve and are not good candidates for surgery.
This study tests whether TAVI (a procedure to replace your heart valve without open-heart surgery) can be done safely at centers that do not have on-site heart surgery backup. It looks at how well patients do after the procedure, focusing on safety and recovery.
This trial studies people with severe aortic valve disease who will receive a catheter-based valve replacement (TAVR). It aims to check how well this approach works for fixing a narrowed or leaky aortic valve, and to monitor outcomes afterward.
Hear when a new Echocardiography trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.